You can find the annual or quarterly income statement of Aeon Biopharma Inc here for insights into the performance and operational efficiency of Aeon Biopharma Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

Operating expenses

-37.00%2.53M

-44.30%4.32M

-61.95%3.95M

-50.07%5.67M

-72.25%4.02M

-44.46%7.76M

-20.43%10.38M

-24.51%11.35M

45.98%14.47M

14.96%13.97M

15.17%13.05M

--15.03M

--9.91M

--12.15M

--11.33M

R&D expenses

-38.58%597.00K

-76.03%1.06M

-85.61%825.00K

-55.73%3.04M

-87.78%972.00K

-50.81%4.44M

-37.73%5.73M

-28.01%6.86M

6.41%7.96M

0.68%9.03M

4.80%9.21M

--9.53M

--7.48M

--8.96M

--8.78M

Depreciation, depletion, and amortization

-24.00%19.00K

-16.67%20.00K

-24.00%19.00K

-4.17%23.00K

-7.41%25.00K

--24.00K

--25.00K

-25.00%24.00K

107.69%27.00K

----

--32.00K

--13.00K

----

Operating profit

37.00%-2.53M

44.30%-4.32M

61.95%-3.95M

50.07%-5.67M

72.25%-4.02M

44.46%-7.76M

20.43%-10.38M

24.51%-11.35M

-45.98%-14.47M

-14.96%-13.97M

-15.17%-13.05M

---15.03M

---9.91M

---12.15M

---11.33M

Net non-operating interest income (expenses)

Special income (expenses)

4.51%-2.08M

-101.40%-2.41M

182.27%88.59M

102.04%7.75M

-104.09%-2.17M

11926.43%171.84M

-2212.13%-107.68M

-1828.60%-379.49M

8081.23%53.16M

-115.05%-1.45M

-174.26%-4.66M

---19.68M

---666.00K

--9.66M

--6.27M

Other non-operating income (expenses)

257.89%68.00K

170.59%92.00K

-193794.87%-75.54M

-99.71%1.00K

-90.05%19.00K

-24.44%34.00K

-39.06%39.00K

138.10%350.00K

35.46%191.00K

4600.00%45.00K

6300.00%64.00K

--147.00K

--141.00K

---1.00K

--1.00K

Income before tax

26.46%-4.54M

-104.05%-6.64M

107.71%9.10M

100.53%2.08M

-115.87%-6.17M

1167.12%164.11M

-569.07%-118.02M

-1029.79%-390.49M

472.44%38.88M

-515.90%-15.38M

-248.87%-17.64M

---34.56M

---10.44M

---2.50M

---5.06M

Income tax

--0.00

----

--0.00

----

--0.00

Income after tax

26.46%-4.54M

-104.05%-6.64M

107.71%9.10M

100.53%2.08M

-115.87%-6.17M

1167.12%164.11M

-569.07%-118.02M

-1029.79%-390.49M

472.44%38.88M

-515.90%-15.38M

-248.87%-17.64M

---34.56M

---10.44M

---2.50M

---5.06M

Net income from continuous operations

26.46%-4.54M

-104.05%-6.64M

107.71%9.10M

100.53%2.08M

-115.87%-6.17M

1167.12%164.11M

-569.07%-118.02M

-1029.79%-390.49M

472.44%38.88M

-515.90%-15.38M

-248.87%-17.64M

---34.56M

---10.44M

---2.50M

---5.06M

Net income attributable to controlling interests

26.46%-4.54M

-104.05%-6.64M

107.71%9.10M

100.53%2.08M

-115.87%-6.17M

1167.12%164.11M

-569.07%-118.02M

-1029.79%-390.49M

472.44%38.88M

-515.90%-15.38M

-248.87%-17.64M

---34.56M

---10.44M

---2.50M

---5.06M

Net income attributable to common shareholders

26.46%-4.54M

-104.05%-6.64M

107.71%9.10M

100.53%2.08M

-115.87%-6.17M

1167.12%164.11M

-569.07%-118.02M

-1029.79%-390.49M

472.44%38.88M

-515.90%-15.38M

-248.87%-17.64M

---34.56M

---10.44M

---2.50M

---5.06M

Basic earnings per share

96.53%-0.39

-100.20%-0.60

101.00%2.28

100.50%3.75

-114.93%-11.24

1120.74%304.20

-567.06%-228.00

-1029.67%-756.61

472.39%75.32

-515.94%-29.80

-248.86%-34.18

---66.98

---20.23

---4.84

---9.80

Diluted earnings per share

96.53%-0.39

-100.20%-0.60

101.00%2.28

100.47%3.58

-114.93%-11.24

1120.74%304.20

-567.06%-228.00

-1029.67%-756.61

472.39%75.32

-515.94%-29.80

-248.86%-34.18

---66.98

---20.23

---4.84

---9.80

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

